Facility Evaluation Report

On 3/31/2023, Licensing Program Analyst (LPA) V Gorban conducted an unannounced Case Management visit.

LPA introduced self and was allowed entrance by staff. LPA met with Program Director Amanda Frantz

LPA arrived at the facility to conduct case management visit for incident report CCLD received with date incident occurred on 3/13/2023 regarding C1 was given a full dose pill of .50 mg instead of .25mg the current taper order.

Side effects are as noted on the medication bottle drowsiness, dizziness.

LPA interviewed Administrator and med personnel. Initial order of Klonopin was prescribed on 3/14/23 one pill once a day. On 3/15/ 23 order was altered, instead of .50 mg once a day, order medication was dispensed .25 mg twice per day per client’s request.

Client was monitored for any possible side effects such as dizziness and nausea.

LPA attempted to interview client. C1 was discharged form facility on 3/16/23 due to step down in assessment.

Facility staff enhance educational training program for med techs on how to handle medications properly, more efficiently, with less errors, and follow proper dose disposal. Completed training will be provided to department once class completed.

An exit interview was conducted with Administrator. Amended report signed on-site and a copy of report was provided.